Mary-Jane co-founded Consilium Strategic Communications in July 2013 having led the management buy-out from M:Communications.
She has more than 20 years of healthcare experience from leading communications agencies and the pharmaceutical industry and is an expert in financial, corporate, investor and scientific communications.
Prior to founding Consilium, Mary-Jane established and led M:Communications’ international healthcare team where she advised public and private companies across all sub-sectors of healthcare and including some of the sector’s leading industry bodies. She has advised on a wide range of high profile IPOs, financings, M&A transactions and industry deals, crisis communications, clinical data findings and product launches.
Mary-Jane worked both as a scientist and in the communications and IR team at PowderJect Pharmaceuticals plc for six years and was previously with Bell Laboratories Inc in Madison, Wisconsin, US. Mary-Jane has a BSc (Hons) in BioMedical Sciences.